NewYork-Presbyterian Queens Appoints New Chair of Radiation Oncology

Aug 13, 2018

Queens, NY

NewYork-Presbyterian Queens announced that Steven Joseph DiBiase, MD, was appointed the new chairman of the Department of Radiation Oncology. He replaces Akkamma Ravi, MBBS, MD who served as interim chair of the Department. 

Prior to his appointment, Dr. DiBiase served as professor of Radiation Oncology at Tulane University and as medical director of the Department of Radiation Oncology at the Tulane Comprehensive Cancer Center in New Orleans. Dr. DiBiase has extensive clinical experience as well as expertise with advanced, precision therapies like Gamma Knife, Cyberknife, and Prostate Brachytherapy.

“You can find some of the best physicians in the world right here in Queens, and Dr. DiBiase is another example of our hospital’s ability to attract some of the best medical talent available,” said Jaclyn Mucaria, president of NewYork-Presbyterian Queens. “Dr. DiBiase has earned a reputation for clinical excellence and his experience with cutting-edge, precision therapies keeps our radiation oncology department at the forefront of cancer care.”

Dr. DiBiase’s arrival coincides with NewYork-Presbyterian Queens’ enhancement of its technology pertaining to radiation oncology treatment. Recently, the hospital purchased a linear accelerator (LINAC) machine which can more accurately focus the radiation treatment on a tumor. This leads to the destruction of the cancerous cells and can more efficiently preserve the surrounding healthy tissues. NewYork-Presbyterian Queens is the only hospital in Queens with this latest technology available. Some treatments that once took 10 to 30 minutes can now be completed in less than two minutes. That makes for a more comfortable treatment experience, and helps patients get back to normal life much quicker.

“NewYork-Presbyterian Queens is a leader in comprehensive cancer care, and it is an exciting time to be joining the hospital,” said Dr. DiBiase, the new chairman of the Department of Radiation Oncology. “I look forward to engaging with the borough’s patients and offering them the most advanced technologies and treatments available to fight cancer.”

In addition to his tenure at Tulane University, Dr. DiBiase has served as professor of Radiology at the University of Tennessee and held multiple faculty positions at the Robert Wood Johnson School of Medicine and at the University of Maryland School of Medicine. Prior to that, he was the medical director of the University of Tennessee Cyberknife Center, the chief of the Department of Radiation Oncology at Cooper University Hospital and the vice-chairman of the Department of Radiation Oncology at Robert Wood Johnson School of Medicine.

Dr. DiBiase’s appointment became official on July 9, 2018.

To download a high resolution photo of Dr. DiBiase click here.

NewYork-Presbyterian Queens

NewYork-Presbyterian Queens, located in Flushing, New York, is a community teaching hospital affiliated with Weill Cornell Medicine, serving Queens and metro New York residents. The 535-bed tertiary care facility provides services in 14 clinical departments and numerous subspecialties.  Annually, 15,000 surgeries and 4,000 infant deliveries are performed at NewYork-Presbyterian Queens. With its network of affiliated primary and multispecialty care physician practices and community-based health centers, the hospital provides approximately 162,000 ambulatory care visits and 124,000 emergency service visits annually. For more information, visit 

Media Contact:

Julie Robinson 212-843-9341